Drawing on the remarkable diversity of placentation across mammals, our group is developing new perspectives on maternal-fetal interactions, and the evolution of stromal fibroblasts, developing new insights into human disease.


Maternal-fetal interface (Endometrium and the placenta) has long been considered as a contested frontier, but we have argued that it also requires co-operation between the maternal and fetal compartments. These conflict+co-operation, which we termed Co-opetition, underlies the large diversity in placentation across mammals, and the many diseases associated with the endometrium.

A key focus of our group is to elucidate the unique biology of endometrium, menstruation, and the mechanisms underlying placental, and endometrial pathologies.

Cycling Hypoxia in Tumors

Hypoxia Inducible Factor 1 (HIF1) is the master regulator of cellular response to lack of oxygen. We showed that HIF-1 transcriptional activity may not be stable, which can allow a small number of cells to escape HIF-1 induced cell cycle arrest. Hypoxia itself is not stable in all regions of the tumor, and these fluctuations can enrichment of stroma-tumor interactions promoting tumor growth.